Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Obliterative bronchiolitis after lung and heart-lung transplantation
Hermann Reichenspurner
, Reda E. Girgis
, Robert C. Robbins
, John V. Conte
, Rajan V. Nair
, Vincent Valentine
, Gerald J. Berry
, Randall E. Morris
, James Theodore
, Bruce A. Reitz
Department of Surgery
Research output
:
Contribution to journal
›
Article
›
peer-review
113
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Obliterative bronchiolitis after lung and heart-lung transplantation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lung
100%
Heart-lung Transplantation
100%
Obliterative Bronchiolitis
100%
Heart-lung
20%
Lung Transplantation
20%
Bronchiolitis Obliterans Syndrome
20%
Improved Management
10%
Cytomegalovirus Infection
10%
New Treatment Options
10%
Growth Factors
10%
Risk Factors
10%
Survival Rate
10%
Acute Rejection
10%
Small Airways
10%
Early Diagnosis
10%
Forced Expiratory Volume in 1 Second (FEV1)
10%
Cellular Events
10%
Scar
10%
Forced Vital Capacity
10%
Transplantation
10%
Molecular Events
10%
Transbronchial Biopsy
10%
Stanford University
10%
Obliteration
10%
Current Limiting
10%
Pulmonary Function Parameters
10%
Final Common Pathway
10%
Alloimmune
10%
Inciting Event
10%
Second Biopsy
10%
Medicine and Dentistry
Bronchiolitis Obliterans
100%
Heart Lung Transplantation
100%
Lung
100%
Lung Transplantation
16%
Cytomegalovirus Infection
8%
Prevalence
8%
Survival Rate
8%
Morbidity
8%
Early Diagnosis
8%
Growth Factor
8%
Scar Formation
8%
Forced Vital Capacity
8%
Forced Expiratory Volume
8%
Acute Graft Rejection
8%
Lung Function
8%
Transbronchial Biopsy
8%
Pathogenesis
8%
Immunology and Microbiology
Lung Transplantation
100%
Bronchiolitis
100%
Lung
100%
Cytomegalovirus Infection
8%
Growth Factor
8%
Prevalence
8%
Survival Rate
8%
Acute Graft Rejection
8%
Experimental Model
8%
Lung Function
8%
Forced Vital Capacity
8%
Morbidity
8%
Scar Formation
8%
Forced Expiratory Volume
8%
Airway
8%